Indications and usage of everolimus in breast cancer treatment

Everolimus (Afinitor), an mTOR inhibitor, has made breakthrough progress in the field of breast cancer treatment in recent years. The U.S. Food and Drug Administration (FDA) has approved everolimus in combination with exemestane (Aromasin) to treat certain patients with advanced breast cancer. This combination therapy is targeted at postmenopausal women who are hormone receptor-positive, HER2-negative, and whose cancer has returned or progressed after treatment with letrozole (Femara) or anastrozole (Arimidex).

The main role of everolimus in the treatment of breast cancer is to interfere with the growth, differentiation and metabolism of cancer cells by inhibiting themTOR signaling pathway. Combined use with exemestane can further enhance the therapeutic effect and prolong the patient's survival.

The recommended dose of everolimus in the treatment of breast cancer is10 mg taken orally once daily. Patients should take the medication at the same time every day to ensure stable blood drug concentrations. When taking the medicine, swallow the tablets whole with a glass of water. Avoid breaking or crushing the tablets, which may affect the effectiveness of the medicine.

If the patient misses a dose while taking the medicine, the dose should be taken as soon as possible. However, if the missed dose exceeds 6 hours, it is recommended to skip the missed dose and not take two doses at once to avoid the potential risk of overdose.

During the use of everolimus, patients should pay close attention to their body's reactions and promptly report any symptoms of discomfort to their doctor. Common side effects include stomatitis, swelling, bone marrow suppression, pneumonia, increased risk of infection, and high blood sugar. Doctors will provide personalized treatment plans and suggestions for dealing with side effects based on the patient's specific situation.

In addition, everolimus may interact with certain medications, so inform your doctor about all medications you are taking, including prescription drugs, over-the-counter drugs, vitamins, and herbal supplements before use.

Overall, everolimus has demonstrated good efficacy and safety in the treatment of breast cancer. However, patients should strictly follow the doctor's instructions when using it, pay attention to the drug dosage and medication time, and pay close attention to the body's reaction to ensure the maximum treatment effect.